KRT17 and cancer: Another cytokeratin, described as a putative heterodimer partner of KRT7, i.e., KRT17, has also been shown to be significantly lower in aggressive cancers (diffuse gastric cancer), similar to the loss of KRT7 staining that we observed in tumoral prostatic glands [58].